David Young (Cambridge University): Publications - PhilPeople

Cambridge University
Faculty of Philosophy

Graduate student

Areas of Interest

Social and Political Philosophy

12

Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity
with Lily Jan, Jan Yuh, S. B. Yang, H. Y. Lee, D. M. Young, A. C. Tien, A. Rowson-Baldwin, Y. Y. Shu, Jan Y. N., and Jan L. Y.

Rapamycin, a specific inhibitor for mTOR complex 1, is an FDA-approved immunosuppressant for organ transplant. Recent developments have raised the prospect of using rapamycin to treat cancer or diabetes and to delay aging. It is therefore important to asse.